Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR ISOSORBIDE MONONITRATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Isosorbide Mononitrate

Subscribe to access the full database, or Try it Free
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00143195 ↗	Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina	Completed	Pfizer	Phase 4	2001-04-01	The objective of study is to compare the anti-ischemic efficacy and safety profiles of once daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and symptomatic myocardial ischemia
NCT00143195 ↗	Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina	Completed	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4	2001-04-01	The objective of study is to compare the anti-ischemic efficacy and safety profiles of once daily amlodipine or isosorbide-5-mononitrate in the treatment of stable asymptomatic and symptomatic myocardial ischemia
NCT00168519 ↗	Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes	Completed	Diabetes Australia	N/A	2002-10-01	The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗	Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes	Completed	Hoffmann-La Roche	N/A	2002-10-01	The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Isosorbide Mononitrate

Condition Name

Chart
Table

Condition Name for Isosorbide Mononitrate
Intervention	Trials
Hypertension	6
Healthy	5
Portal Hypertension	2
Contraception	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Isosorbide Mononitrate
Intervention	Trials
Hypertension	6
Headache	3
Coronary Artery Disease	2
Angina Pectoris	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Isosorbide Mononitrate

Trials by Country

Map
Table

Trials by Country for Isosorbide Mononitrate
Location	Trials
United States	20
Egypt	11
Denmark	4
India	3
China	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Isosorbide Mononitrate
Location	Trials
Pennsylvania	3
Texas	2
Ohio	2
Georgia	1
Delaware	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Isosorbide Mononitrate

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Isosorbide Mononitrate
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	9
Phase 2/Phase 3	2
[disabled in preview]	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Isosorbide Mononitrate
Clinical Trial Phase	Trials
Completed	29
Unknown status	7
Not yet recruiting	3
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Isosorbide Mononitrate

Sponsor Name

Chart
Table

Sponsor Name for Isosorbide Mononitrate
Sponsor	Trials
Cairo University	5
Merck Sharp & Dohme Corp.	3
Danish Headache Center	3
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Isosorbide Mononitrate
Sponsor	Trials
Other	56
Industry	17
NIH	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Colorcon

Baxter

Johnson and Johnson

AstraZeneca

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.